Filing Details

Accession Number:
0001140361-24-009271
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-02-23 16:37:35
Reporting Period:
2024-02-21
Accepted Time:
2024-02-23 16:37:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
9326 Balchem Corp BCPC Chemicals & Allied Products (2800) 132578432
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1378228 L Theodore Harris C/O Balchem Corporation
5 Paragon Drive
Montvale NJ 07645
Chairman, President & Ceo No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-02-21 10,797 $152.97 85,294 No 4 S Direct
Common Stock Disposition 2024-02-21 16,015 $153.75 69,279 No 4 S Direct
Common Stock Disposition 2024-02-21 2,667 $154.84 66,612 No 4 S Direct
Common Stock Disposition 2024-02-21 200 $155.91 66,412 No 4 S Direct
Common Stock Acquisiton 2024-02-22 10,000 $54.87 76,412 No 4 M Direct
Common Stock Acquisiton 2024-02-22 24,350 $60.85 100,762 No 4 M Direct
Common Stock Disposition 2024-02-22 14,497 $153.56 86,265 No 4 S Direct
Common Stock Disposition 2024-02-22 13,989 $154.66 72,276 No 4 S Direct
Common Stock Disposition 2024-02-22 5,864 $155.25 66,412 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options (right to buy) Acquisiton 2024-02-22 10,000 $0.00 10,000 $54.87
Common Stock Stock Options (right to buy) Acquisiton 2024-02-22 24,350 $0.00 24,350 $60.85
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2025-04-28 No 4 M Direct
0 2026-02-23 No 4 M Direct
Footnotes
  1. This transaction was executed in multiples sales ranging from $152.3350 to $153.3200 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.
  2. This transaction was executed in multiples sales ranging from $153.3400 to $154.2900 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.
  3. This transaction was executed in multiples sales ranging from $154.4700 to $155.3800 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.
  4. Exercise of fully vested non-qualified stock options.
  5. This transaction was executed in multiple sales ranging from $153.0800 to $154.0775 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.
  6. This transaction was executed in multiple sales ranging from $154.0800 to $155.0750 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.
  7. This transaction was executed in multiple sales ranging from $155.0800 to $155.5700 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.
  8. Stock options that vested 20% on April 28, 2016, 40% on April 28, 2017, and 40% on April 28, 2018, and are exercisable.
  9. Stock options that vested 20% on February 23, 2017, 40% on February 23, 2018, and 40% on February 23, 2019, and are exercisable.